Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Kaposi 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Doxorubicin 5tecogalan 4Liposomes 4Vincristine 3Semaxinib 3Bleomycin 3technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2Alitretinoin 2vesnarinone 1tin etiopurpurin 1daromun 1Tumor Necrosis Factor-alpha 1Ro 24-7429 1Ritonavir 1Quality of Life 1Patient Reported Outcome Measures 1Paclitaxel 1Nelfinavir 1Molecular Diagnostic Techniques 1Mitoxantrone 1Immunotherapy 1Drug Therapy 1Daunorubicin 1Brentuximab Vedotin 1Biological Therapy 1Bexarotene 14,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 13-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Sarcoma, Kaposi × Ro 24-7429 × Clear all
NCT00002314 2005-06-24

A Study of Ro 24-7429 in Patients With HIV-Related Kaposi's Sarcoma

NIH AIDS Clinical Trials Information Service

Phase 2 Completed
Sarcoma

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡